ORGS Orgenesis Inc Company Cash Funds

ORGS (Orgenesis Corp) - company brandmark

The trend toward decentralized live cell manufacturing is reducing therapy delivery times. The GURU.Markets platform features this chart, where the company's cash position demonstrates price action, and 0.00 indicates the current level. However, strict FDA oversight and patent barriers are limiting growth, while financial difficulties and pressure from corporate behemoths are forcing Orgenesis Inc. (ORGS) to fight for survival in the market.

ORGS - Orgenesis Corporation Company Cash on Hand over the range 07/04/2022 - 10/26/2024

Summary analytical data breakdowns for Orgenesis Inc (ORGS)

- stock quotes and analyst forecast:
Fundamental valuation:Orgenesis Corporation
Signature product of Orgenesis

This indicator reflects instantaneous liquidity, reacting promptly to cash inflows and outflows. It measures the volume of available assets on accounts, allowing for an assessment of the company's ability to fund operating activities without external borrowing. For Orgenesis Inc. (ORGS), this reserve is critically important when implementing gene therapy, where demand is dictated by biological necessity rather than market cycles. The history of cash balances confirms the efficiency of capital utilization. An excess of funds may indicate stagnant development.

Competitor analysis

Company Cash Volume VEEV|Doximity, Inc. - Company Cash and Cash Equivalents|HealthEquity - Company Cash on Hand|Company Liquid Assets Waystar Health (WAY)|CRVL - Company Cash Funds|Company Cash Balance PRVA (Privia Health Group)|HURN: Company Cash Volume|Company Cash Reserve certara.com (CERT)|Company Cash Funds Omnicell Inc|GoodRx Corp (GDRX) - Company Liquid Assets|Company Cash on Hand SDGR (Schrodinger Corp)|Company Liquid Assets Phreesia, Inc.|Company Cash Funds Omada Health, Inc. OMDA|EVH - Company Cash on Hand|HealthStream - Company Cash Volume|Company Cash Balance DH (Definitive Healthcare Corp.)|Consensus (CCSI) - Company Cash Funds|Company Cash on Hand agilon health Inc|ABSI (absci.com) - Company Cash Volume|Company Cash Funds SY|Company Cash on Hand NRC (National Research Corp)|SPOK - Company Cash Reserve|Company Cash Funds OptimizeRx Corporation OPRX|TBRG - Company Cash on Hand|SLP - Company Cash Funds|Company Liquid Assets Sophia Genetics SOPH|HCAT (Health Catalyst, Inc.) - Company Cash on Hand|Company Cash and Cash Equivalents CCLD|Company Cash on Hand RSSS|DLHC: Company Cash Balance|Company Cash Volume ONMD|Scienture Holdings Inc - Company Cash and Cash Equivalents|Company Cash Funds Healthcare Triangle Inc HCTI|ISPC (iSpecimen Corp) - Company Total Cash Volume|BFRG - Company Cash Funds|WORX (SCWorx Corp.) - Company Cash and Cash Equivalents|LifeWallet (MSPR) - Company Cash Funds|Company Cash on Hand iCoreConnect Corp|Company Cash Funds TRxADE HEALTH|RCM: Company Cash Balance|Company Cash Volume SHCR|Company Cash on Hand Streamline Health Solutions Inc. STRM|Syra Health Corp. - Company Cash on Hand|ApolloMed (AMEH) - Company Cash Reserve|Model N Inc - Company Cash Volume|Company Cash Position NextGen Healthcare, Inc. (NXGN)